When was Longenesis founded?

Longenesis was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Longenesis located?

Longenesis is headquartered in Riga, Latvia. It is registered at Rīga, Zaubes iela 9A - 23.

Who is the current CEO of Longenesis?

Emil Syundyukov of Longenesis. They have also founded 1 company.

Which legal entities is Longenesis associated with?

Longenesis is associated with LONGENESIS.

How many employees does Longenesis have?

As of Apr 30, 2026, the latest employee count at Longenesis is 19.

Is Longenesis a funded company?

Longenesis is a funded company, having raised a total of $1.19M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 02, 2020.

When was the latest funding round of Longenesis?

Longenesis' latest funding was a $***** Seed round on Jun 30, 2021, with participation from 2 investors.

What is the annual revenue of Longenesis?

Annual revenue of Longenesis is €658K as on Dec 31, 2024.

Where does Longenesis rank among its competitors?

Longenesis ranks 57th amongst 581 active competitors, of which 93 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Zocalo Health, which secured $22.6M in Feb, 2026.

Who are the top competitors of Longenesis?

Longenesis' top competitors include Hyro, ConnectiveRx and ixLayer. Among them, Zocalo Health secured the most recent funding round in February, 2026.

Longenesis - 2026 Company Profile, Team, Funding, Competitors & Financials

Longenesis is a seed company based in Riga (Latvia), founded in 2017 by Garri Zmudze, Sergey Jakimov and Emil Syundyukov. It operates as a Digital platform for healthcare research and patient engagement. Longenesis has raised $1.19M in funding. The company has 581 active competitors, including 93 funded and 43 that have exited. Its top competitors include companies like Hyro, ConnectiveRx and ixLayer.

Company Details

Digital platform for healthcare research and patient engagement. The company offers digital tools for patient cohort discovery, patient engagement and consent management for life science companies and healthcare institutions.

Website: longenesis.com
Social
Email ID: *****@longenesis.com
Phone Number: +852 **********
Registered Address: Rīga, Zaubes iela 9A - 23

Key Metrics

Founded Year

2017

Location

Riga, Latvia

Stage

Seed

Total Funding

$1.19M in 2 rounds

Latest Funding Round

Seed, Jun 30, 2021, $*****

Investors

Rustam Gilfanov & 5 more

Ranked

57^th among 581 active competitors

Annual Revenue

€658K as on Dec 31, 2024

Employee Count

19 as on Apr 30, 2026

Similar Companies

Hyro & 741 more

View Longenesis' full profile

Longenesis is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LONGENESIS CIN: 40203211852 , Latvia, Active	May 17, 2019	$712K (As on Dec 31, 2024)	16 (As on Dec 31, 2022)	-

Longenesis has raised a total funding of $1.19M over 2 rounds. Its first funding round was on Jun 02, 2020. Its latest funding round was a Seed round on Jun 30, 2021 for $*****. 2 investors participated in its latest round. Longenesis has 4 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Longenesis:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 30, 2021	7035813	Seed	9425238	3223771	5734943	4402171
Jun 02, 2020	7888224	Grant (prize money)	8274613	2254209	3802275	EIT Health

Access funding benchmarks and valuations. Sign up today!

View details of Longenesis's funding rounds and investors

The founders of Longenesis are Garri Zmudze, Sergey Jakimov and Emil Syundyukov. Emil Syundyukov is the CEO of Longenesis.

Here are the details of Longenesis' key team members:

Garri Zmudze: Co-Founder of Longenesis and founder of 1 other company.
Sergey Jakimov: Co-Founder of Longenesis.
Contact Info: 1 email address
Emil Syundyukov: Co-Founder & CEO of Longenesis.

View details of Longenesis's Founder profiles and Board Members

Longenesis' employee count trend

Longenesis has 19 employees as of Apr 26. Here is Longenesis's employee count trend over the years:

Uncover Longenesis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Longenesis include Hyro, ConnectiveRx and ixLayer. Here is the list of Top 10 competitors of Longenesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Hyro 2014, New York City (United States), Series C	Provider of an AI-based conversational platform	$115M	Healthier Capital, Spider Capital & 16 others	70/100
2nd	ConnectiveRx 2008, Hanover (United States), Acquired	Provider of patient engagement and prior authorization solutions	$300M	Harvest Partners, Blackstone & 8 others	66/100
3rd	ixLayer 2017, San Francisco (United States), Series A	Provider of cloud-based solution for precision and population health testing	$75M	Salesforce, General Catalyst & 14 others	66/100
4th	CipherHealth 2009, New York City (United States), Series A	Patient-facing operating system for consistent healthcare operations and exceptional experiences	$37.6M	JMI Management, Canadian Imperial Bank of Commerce ... & 2 others	65/100
5th	b.well 2015, Eldersburg (United States), Series C	Customised healthcare with rewards for reaching personal health goals	$96.3M	HLM Venture Partners, UnityPoint Health Ventures ... & 18 others	62/100
6th	GetWellNetwork 1999, Bethesda (United States), Acquired	Interactive Patient engagement software to help hospitals get patients more involved in their care process	$19M	Industry Ventures, The Grosvenor Funds & 13 others	62/100
7th	PatientPoint 1987, Cincinnati (United States), Acquired	Patient engagement solutions for healthcare providers at point of care	$140M	ACE & Company, Transformation Capital & 5 others	61/100
8th	Zocalo Health 2021, Seattle (United States), Series A	Provider of mental, emotional, and spiritual wellbeing services	$30.6M	Animo, VamosVentures & 14 others	61/100
9th	Ostro 2019, Miami (United States), Acquired	Saas-based patient engagement platform for healthcare providers	$55M	Founders Fund, Byers Capital & 7 others	59/100
10th	Giotto Technologies 2017, Switzerland, Acquired	Developer of reasoning technology designed to advance artificial general intelligence	$5.02M	Faster Capital, Park House Partners	58/100
57th	Longenesis 2017, Riga (Latvia), Seed	Digital platform for healthcare research and patient engagement	$1.19M	MedTech Innovator, R3i Capital & 4 others	43/100